BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11915030)

  • 1. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.
    Fantappiè O; Masini E; Sardi I; Raimondi L; Bani D; Solazzo M; Vannacci A; Mazzanti R
    Hepatology; 2002 Apr; 35(4):843-52. PubMed ID: 11915030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
    Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R
    Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts].
    Yao HP; Shao XT; Sun WJ; Shao CS; Zhang LH
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):277-82. PubMed ID: 12621554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane.
    Fantappiè O; Sassoli C; Tani A; Nosi D; Marchetti S; Formigli L; Mazzanti R
    J Cell Mol Med; 2015 Jun; 19(6):1410-7. PubMed ID: 25691007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
    Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
    Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
    Pelletier JP; Fernandes JC; Jovanovic DV; Reboul P; Martel-Pelletier J
    J Rheumatol; 2001 Nov; 28(11):2509-19. PubMed ID: 11708426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
    Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
    Fantappiè O; Solazzo M; Lasagna N; Platini F; Tessitore L; Mazzanti R
    Cancer Res; 2007 May; 67(10):4915-23. PubMed ID: 17510421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth.
    Ishimura N; Bronk SF; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G88-95. PubMed ID: 14977638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.
    Rahman MA; Dhar DK; Yamaguchi E; Maruyama S; Sato T; Hayashi H; Ono T; Yamanoi A; Kohno H; Nagasue N
    Clin Cancer Res; 2001 May; 7(5):1325-32. PubMed ID: 11350902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma.
    Gallo O; Schiavone N; Papucci L; Sardi I; Magnelli L; Franchi A; Masini E; Capaccioli S
    Am J Pathol; 2003 Aug; 163(2):723-32. PubMed ID: 12875991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.
    Cianchi F; Cortesini C; Fantappiè O; Messerini L; Sardi I; Lasagna N; Perna F; Fabbroni V; Di Felice A; Perigli G; Mazzanti R; Masini E
    Clin Cancer Res; 2004 Apr; 10(8):2694-704. PubMed ID: 15102673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids.
    Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K
    Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK506 enhances triptolide-induced down-regulation of cyclooxygenase-2, inducible nitric oxide synthase as well as their products PGE2 and NO in TNF-alpha-stimulated synovial fibroblasts from rheumatoid arthritic patients.
    Yao H; Zhou J; Li D; Wu N; Bader A; Höxtermann S; Altmeyer P; Brockmeyer NH
    Eur J Med Res; 2005 Mar; 10(3):110-6. PubMed ID: 15851377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in rat gastric mucosa: effect of cyclooxygenase activity on nitric oxide production.
    Uno K; Iuchi Y; Fujii J; Sugata H; Iijima K; Kato K; Shimosegawa T; Yoshimura T
    J Pharmacol Exp Ther; 2004 Jun; 309(3):995-1002. PubMed ID: 14988416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
    J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.